Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-009682
Filing Date
2024-12-11
Accepted
2024-12-11 16:48:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3258
  Complete submission text file 0001950047-24-009682.txt   4649
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Subject) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38276 | Film No.: 241542116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address
Watson David O. (Reporting) CIK: 0001657719 (see all company filings)

Type: 144